Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL434262 | 1.00 | CYP2C19 (0.43) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL4235762 | 0.84 | CYP2C19 (0.45) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL30018891 | 0.83 | CES2 (0.49) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL311166 | 0.81 | CYP2C19 (0.59) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL21457582 | 0.81 | ALDH1A1 (0.46) | CYP2C19KMT2AMEN1ALDH1A1CES1 | |
| SCHEMBL6418982 | 0.79 | KMT2A (0.52) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL1898420 | 0.79 | KMT2A (0.52) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL79975 | 0.79 | KMT2A (0.52) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL2882619 | 0.78 | HSD17B10 (0.47) | CYP2C19CYP1A2CYP2C9KMT2AMEN1 | |
| SCHEMBL15879449 | 0.78 | CLCN2 (0.37) | CYP2C19CYP1A2CYP2C9ALDH1A1CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 764 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021122039-A1 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | L'OREAL (FR) | 2021-06-24 | — | — | WO | claimed |
| US-10632096-B2 | Method of quenching singlet and triplet excited states of photodegradable pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds having electron withdrawing groups, to reduce generation of singlet oxygen | HallStar Beauty and Personal Care Innovations Company (US) | 2020-04-28 | — | — | US | claimed |
| EP-3024429-A2 | UV COMPOSITIONS HAVING LOW ACTIVE CONCENTRATIONS AND HIGH IN VIVO SPF | The Procter & Gamble Company (US) | 2016-06-01 | — | — | EP | claimed |
| US-9351913-B2 | SPF liquid cleansing compositions and methods of use | COCKERELL DERMATOLOGY DEVELOPMENT, LTD. (US) | 2016-05-31 | — | — | US | claimed |
| US-20150059792-A1 | SPF LIQUID CLEANSING COMPOSITIONS AND METHODS OF USE | COCKERELL DERMATOLOGY DEVELOPMENT, LTD. | 2015-03-05 | — | — | US | claimed |
| US-8945703-B2 | Single- or multilayer, stabilized polyester film | MITSUBISHI POLYESTER FILM GMBH (DE) | 2015-02-03 | — | — | US | claimed |
| WO-2015013198-A2 | UV COMPOSITIONS HAVING LOW ACTIVE CONCENTRATIONS AND HIGH IN VIVO SPF | THE PROCTER & GAMBLE COMPANY (US) | 2015-01-29 | — | — | WO | claimed |
| US-8877166-B2 | SPF liquid cleansing compositions | COCKERELL DERMATOLOGY DEVELOPMENT, LTD. (US) | 2014-11-04 | — | — | US | claimed |
| EP-1719637-B1 | Security document with ultraviolet authentication security feature and method of applying a security feature to a security document. | CANADIAN BANK NOTE CO LTD (CA) | 2014-06-18 | — | — | EP | claimed |
| WO-2014025370-A1 | TRICYCLIC ENERGY QUENCHER COMPOUNDS FOR REDUCING SINGLET OXYGEN GENERATION | HALLSTAR INNOVATIONS CORP. (US) | 2014-02-13 | — | — | WO | claimed |
| EP-0821709-A1 | POLYKETONE POLYMER COMPOSITION | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1998-02-04 | — | — | EP | claimed |
| WO-1996033236-A1 | POLYKETONE POLYMER COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1996-10-24 | — | — | WO | claimed |
| EP-0601080-B1 | FILTERING COSMETIC COMPOSITION CONTAINING A LIPOSOLUBLE FILTER POLYMER WITH HYDROCARBONATED STRUCTURE AND A FILTER SILICONE | OREAL (FR) | 1995-07-26 | — | — | EP | claimed |
| EP-0555460-B1 | FILTERING COSMETIC COMPOSITION COMPRISING A NANOPIGMENT OF METAL OXIDE AND A LIPOSOLUBLE FILTER POLYMER | OREAL (FR) | 1995-05-31 | — | — | EP | claimed |
| EP-0601080-A1 | FILTERING COSMETIC COMPOSITION CONTAINING A LIPOSOLUBLE FILTER POLYMER WITH HYDROCARBONATED STRUCTURE AND A FILTER SILICONE. | OREAL (FR) | 1994-06-15 | — | — | EP | claimed |
| EP-0581942-A1 | ALUMINUM WHEEL CLEARCOAT WITH UV ADDITIVE TO RETARD FILIFORM CORROSION | MORTON INTERNATIONAL, INC. (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0555460-A1 | FILTERING COSMETIC COMPOSITION COMPRISING A NANOPIGMENT OF METAL OXIDE AND A LIPOSOLUBLE FILTER POLYMER. | OREAL (FR) | 1993-08-18 | — | — | EP | claimed |
| WO-1993013875-A1 | ALUMINUM WHEEL CLEARCOAT WITH UV ADDITIVE TO RETARD FILIFORM CORROSION | MORTON INTERNATIONAL, INC. (US) | 1993-07-22 | — | — | WO | claimed |
| WO-1993004666-A1 | FILTERING COSMETIC COMPOSITION COMPRISING A NANOPIGMENT OF METAL OXIDE AND A LIPOSOLUBLE FILTER POLYMER | L'OREAL (FR) | 1993-03-18 | — | — | WO | claimed |
| WO-1993004665-A1 | FILTERING COSMETIC COMPOSITION CONTAINING A LIPOSOLUBLE FILTER POLYMER WITH HYDROCARBONATED STRUCTURE AND A FILTER SILICONE | L'OREAL (FR) | 1993-03-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150059792-A1 | SPF LIQUID CLEANSING COMPOSITIONS AND METHODS OF USE | RARG, STRA6, RARA | CYP2C19 3427/4885CYP1A2 3377/4885CYP2C9 3604/4885 |
| US-10632096-B2 | Method of quenching singlet and triplet excited states of photodegradable pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds having electron withdrawing groups, to reduce generation of singlet oxygen | CBR3, NOX3, CCND3 | CYP2C19 1406/4885CYP1A2 1783/4885CYP2C9 799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.